Mitochondria in cardiac hypertrophy and heart failure

Journal of Molecular and Cellular Cardiology

Volumn 55, Issue 1, 2013, Pages 31-41

  Rosca, Mariana G ^a   Tandler, Bernard ^b   Hoppel, Charles L ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cardiac hypertrophy; Heart failure; Mitochondria; Oxidative phosphorylation

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CELL NUCLEUS DNA; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; RENIN;

ADRENERGIC SYSTEM; BIOENERGY; BIOGENESIS; CELL TYPE; CONGESTIVE CARDIOMYOPATHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENERGY RESOURCE; HEART FAILURE; HEART HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HUMAN; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; NEUROENDOCRINE SYSTEM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEOMICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; HEART FAILURE; HUMANS; MITOCHONDRIA, HEART; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84872676487     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.09.002     Document Type: Review

References (135)

1. McMurray J.J., Pfeffer M.A. Heart failure. Lancet May 28-Jun 3 2005, 365(9474):1877-1889.
2. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med Mar 15 2007, 356(11):1140-1151.
3. Dayer M., Cowie M.R. Heart failure: diagnosis and healthcare burden. Clin Med Jan-Feb 2004, 4(1):13-18.
4. Andersson D.C., Fauconnier J., Yamada T., Lacampagne A., Zhang S.J., Katz A., et al. Mitochondrial production of reactive oxygen species contributes to the beta-adrenergic stimulation of mouse cardiomycytes. J Physiol Apr 1 2011, 589(Pt 7):1791-1801.
5. Dai D.F., Johnson S.C., Villarin J.J., Chin M.T., Nieves-Cintron M., Chen T., et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res Apr 1 2011, 108(7):837-846.
6. Doenst T., Pytel G., Schrepper A., Amorim P., Farber G., Shingu Y., et al. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc Res Jun 1 2010, 86(3):461-470.
7. Lindenmayer G.E., Sordahl L.A., Harigaya S., Allen J.C., Besch H.R., Schwartz A. Some biochemical studies on subcellular systems isolated from fresh recipient human cardiac tissue obtained during transplantation. Am J Cardiol Mar 1971, 27(3):277-283.
8. Rosca M.G., Vazquez E.J., Kerner J., Parland W., Chandler M.P., Stanley W., et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res Oct 1 2008, 80(1):30-39.
9. Sharov V.G., Goussev A., Lesch M., Goldstein S., Sabbah H.N. Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol Sep 1998, 30(9):1757-1762.
10. Sharov V.G., Todor A.V., Silverman N., Goldstein S., Sabbah H.N. Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol Dec 2000, 32(12):2361-2367.
11. Sebastiani M., Giordano C., Nediani C., Travaglini C., Borchi E., Zani M., et al. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol Oct 2 2007, 50(14):1362-1369.
12. Graham B.H., Waymire K.G., Cottrell B., Trounce I.A., MacGregor G.R., Wallace D.C. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet Jul 1997, 16(3):226-234.
13. Puccio H., Simon D., Cossee M., Criqui-Filipe P., Tiziano F., Melki J., et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet Feb 2001, 27(2):181-186.
14. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet Dec 1995, 11(4):376-381.
15. Hansson A., Hance N., Dufour E., Rantanen A., Hultenby K., Clayton D.A., et al. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc Natl Acad Sci U S A Mar 2 2004, 101(9):3136-3141.
16. Shende P., Plaisance I., Morandi C., Pellieux C., Berthonneche C., Zorzato F., et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation Mar 15 2011, 123(10):1073-1082.
17. Iemitsu M., Miyauchi T., Maeda S., Sakai S., Fujii N., Miyazaki H., et al. Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res Oct 2003, 26(10):829-837.
18. Nishio M.L., Ornatsky O.I., Craig E.E., Hood D.A. Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats. Can J Physiol Pharmacol May 1995, 73(5):630-637.
19. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol Sep 1 2003, 551(Pt 2):491-501.
20. Scheubel R.J., Tostlebe M., Simm A., Rohrbach S., Prondzinsky R., Gellerich F.N., et al. Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J Am Coll Cardiol Dec 18 2002, 40(12):2174-2181.
21. Griffiths E.R., Friehs I., Scherr E., Poutias D., McGowan F.X., Del Nido P.J. Electron transport chain dysfunction in neonatal pressure-overload hypertrophy precedes cardiomyocyte apoptosis independent of oxidative stress. J Thorac Cardiovasc Surg Jun 2010, 139(6):1609-1617.
22. Dai D.F., Hsieh E.J., Liu Y., Chen T., Beyer R.P., Chin M.T., et al. Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovasc Res Jan 1 2012, 93(1):79-88.
23. Bugger H., Schwarzer M., Chen D., Schrepper A., Amorim P.A., Schoepe M., et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res Jan 15 2010, 85(2):376-384.
24. Jullig M., Hickey A.J., Chai C.C., Skea G.L., Middleditch M.J., Costa S., et al. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics Jun 2008, 8(12):2556-2572.
25. Rosca M.G., Hoppel C.L. New aspects of impaired mitochondrial function in heart failure. J Bioenerg Biomembr Apr 2009, 41(2):107-112.
26. Rosca M.G., Hoppel C.L. Mitochondria in heart failure. Cardiovasc Res Oct 1 2010, 88(1):40-50.
27. Marin-Garcia J., Goldenthal M.J., Moe G.W. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res Oct 2001, 52(1):103-110.
28. Marin-Garcia J., Goldenthal M.J., Moe G.W. Mitochondrial pathology in cardiac failure. Cardiovasc Res Jan 2001, 49(1):17-26.
29. Moe G.W., Marin-Garcia J., Konig A., Goldenthal M., Lu X., Feng Q. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure. Am J Physiol Oct 2004, 287(4):H1813-H1820.
30. Jarreta D., Orus J., Barrientos A., Miro O., Roig E., Heras M., et al. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc Res Mar 2000, 45(4):860-865.
31. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res Aug 20 1999, 85(4):357-363.
32. Buchwald A., Till H., Unterberg C., Oberschmidt R., Figulla H.R., Wiegand V. Alterations of the mitochondrial respiratory chain in human dilated cardiomyopathy. Eur Heart J Jun 1990, 11(6):509-516.
33. Sparagna G.C., Chicco A.J., Murphy R.C., Bristow M.R., Johnson C.A., Rees M.L., et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res Jul 2007, 48(7):1559-1570.
34. Quigley A.F., Kapsa R.M., Esmore D., Hale G., Byrne E. Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J Card Fail Mar 2000, 6(1):47-55.
35. Liu J., Wang C., Murakami Y., Gong G., Ishibashi Y., Prody C., et al. Mitochondrial ATPase and high-energy phosphates in failing hearts. Am J Physiol Sep 2001, 281(3):H1319-H1326.
36. McCutcheon L.J., Cory C.R., Nowack L., Shen H., Mirsalami M., Lahucky R., et al. Respiratory chain defect of myocardial mitochondria in idiopathic dilated cardiomyopathy of Doberman pinscher dogs. Can J Physiol Pharmacol Nov 1992, 70(11):1529-1533.
37. Unverferth D.V., Lee S.W., Wallick E.T. Human myocardial adenosine triphosphatase activities in health and heart failure. Am Heart J Jan 1988, 115(1 Pt 1):139-146.
38. Schultheiss H.P. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Basic Res Cardiol 1992, 87(Suppl. 1):311-320.
39. Sylven C., Lin L., Jansson E., Sotonyi P., Fu L.X., Waagstein F., et al. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res Jul 1993, 27(7):1295-1299.
40. Dorner A., Schultheiss H.P. The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy. Herz May 2000, 25(3):176-180.
41. Dorner A., Giessen S., Gaub R., Grosse Siestrup H., Schwimmbeck P.L., Hetzer R., et al. An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy. Eur J Heart Fail Jan 2006, 8(1):81-89.
42. Puchowicz M.A., Varnes M.E., Cohen B.H., Friedman N.R., Kerr D.S., Hoppel C.L. Oxidative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria-case studies. Mitochondrion Sep 2004, 4(5-6):377-385.
43. Faustin B., Rossignol R., Rocher C., Benard G., Malgat M., Letellier T. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem May 7 2004, 279(19):20411-20421.
44. Rossignol R., Malgat M., Mazat J.P., Letellier T. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem Nov 19 1999, 274(47):33426-33432.
45. Groen A.K., Wanders R.J., Westerhoff H.V., van der Meer R., Tager J.M. Quantification of the contribution of various steps to the control of mitochondrial respiration. J Biol Chem Mar 25 1982, 257(6):2754-2757.
46. Gellerich F.N., Bohnensack R., Kunz W. Control of mitochondrial respiration. The contribution of the adenine nucleotide translocator depends on the ATP- and ADP-consuming enzymes. Biochim Biophys Acta Feb 17 1983, 722(2):381-391.
47. Lemieux H., Semsroth S., Antretter H., Hofer D., Gnaiger E. Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heart. Int J Biochem Cell Biol Dec 2011, 43(12):1729-1738.
48. Villani G., Attardi G. In vivo control of respiration by cytochrome c oxidase in human cells. Free Radic Biol Med Aug 2000, 29(3-4):202-210.
49. Kadenbach B., Huttemann M., Arnold S., Lee I., Bender E. Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med Aug 2000, 29(3-4):211-221.
50. Sordahl L.A., McCollum W.B., Wood W.G., Schwartz A. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol Mar 1973, 224(3):497-502.
51. Gong G., Liu J., Liang P., Guo T., Hu Q., Ochiai K., et al. Oxidative capacity in failing hearts. Am J Physiol Aug 2003, 285(2):H541-H548.
52. Sanbe A., Tanonaka K., Niwano Y., Takeo S. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment. J Pharmacol Exp Ther Apr 1994, 269(1):51-56.
53. Palmer J.W., Tandler B., Hoppel C.L. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem Dec 10 1977, 252(23):8731-8739.
54. Palmer J.W., Tandler B., Hoppel C.L. Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: effects of procedural manipulations. Arch Biochem Biophys Feb 1 1985, 236(2):691-702.
55. Lindenmayer G.E., Sordahl L.A., Schwartz A. Reevaluation of oxidative phosphorylation in cardiac mitochondria from normal animals and animals in heart failure. Circ Res Sep 1968, 23(3):439-450.
56. Hoppel C.L., Tandler B., Parland W., Turkaly J.S., Albers L.D. Hamster cardiomyopathy. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J Biol Chem Feb 10 1982, 257(3):1540-1548.
57. Lindenmayer G.E., Harigaya S., Bajusz E., Schwartz A. Oxidative phosphorylation and calcium transport of mitochondria isolated from cardiomyopathic hamster hearts. J Mol Cell Cardiol Sep 1970, 1(3):249-259.
58. Wrogemann K., Blanchaer M.C., Jacobson B.E. Oxidative phosphorylation in cardiomyopathic hamsters. Am J Physiol Jun 1972, 222(6):1453-1457.
59. Abel E.D., Doenst T. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc Res May 1 2011, 90(2):234-242.
60. Walther T., Tschope C., Sterner-Kock A., Westermann D., Heringer-Walther S., Riad A., et al. Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease. Circulation Jan 23 2007, 115(3):333-344.
61. Schulz T.J., Westermann D., Isken F., Voigt A., Laube B., Thierbach R., et al. Activation of mitochondrial energy metabolism protects against cardiac failure. Aging Nov 2010, 2(11):843-853.
62. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med May 31 1990, 322(22):1561-1566.
63. Haider A.W., Larson M.G., Benjamin E.J., Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol Nov 1998, 32(5):1454-1459.
64. Bers D.M. Cardiac excitation-contraction coupling. Nature Jan 10 2002, 415(6868):198-205.
65. Xiao R.P., Avdonin P., Zhou Y.Y., Cheng H., Akhter S.A., Eschenhagen T., et al. Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res Jan 8-22 1999, 84(1):43-52.
66. Kilts J.D., Gerhardt M.A., Richardson M.D., Sreeram G., Mackensen G.B., Grocott H.P., et al. Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). Circ Res Oct 13 2000, 87(8):705-709.
67. 2+ current in single rat ventricular cells. Circ Res Aug 1993, 73(2):286-300.
68. Chesley A., Lundberg M.S., Asai T., Xiao R.P., Ohtani S., Lakatta E.G., et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res Dec 8 2000, 87(12):1172-1179.
69. Zhu W.Z., Zheng M., Koch W.J., Lefkowitz R.J., Kobilka B.K., Xiao R.P. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A Feb 13 2001, 98(4):1607-1612.
70. Morisco C., Seta K., Hardt S.E., Lee Y., Vatner S.F., Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem Jul 27 2001, 276(30):28586-28597.
71. Morisco C., Zebrowski D., Condorelli G., Tsichlis P., Vatner S.F., Sadoshima J. The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem May 12 2000, 275(19):14466-14475.
72. Communal C., Singh K., Pimentel D.R., Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation Sep 29 1998, 98(13):1329-1334.
73. Communal C., Singh K., Sawyer D.B., Colucci W.S. Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation Nov 30 1999, 100(22):2210-2212.
74. Alderman E.L., Harrison D.C. Myocardial hypertrophy resulting from low dosage isoproterenol administration in rats. Proc Soc Exp Biol Med Jan 1971, 136(1):268-270.
75. Morisco C., Zebrowski D.C., Vatner D.E., Vatner S.F., Sadoshima J. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart. J Mol Cell Cardiol Mar 2001, 33(3):561-573.
76. Engelhardt S., Hein L., Keller U., Klambt K., Lohse M.J. Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res Apr 19 2002, 90(7):814-819.
77. Bisognano J.D., Weinberger H.D., Bohlmeyer T.J., Pende A., Raynolds M.V., Sastravaha A., et al. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol May 2000, 32(5):817-830.
78. Gaudin C., Ishikawa Y., Wight D.C., Mahdavi V., Nadal-Ginard B., Wagner T.E., et al. Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest Apr 1995, 95(4):1676-1683.
79. Antos C.L., Frey N., Marx S.O., Reiken S., Gaburjakova M., Richardson J.A., et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res Nov 23 2001, 89(11):997-1004.
80. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med May 23 1996, 334(21):1349-1355.
81. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet Jun 12 1999, 353(9169):2001-2007.
82. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet Jan 2 1999, 353(9146):9-13.
83. Fauconnier J., Andersson D.C., Zhang S.J., Lanner J.T., Wibom R., Katz A., et al. Effects of palmitate on Ca(2+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes Apr 2007, 56(4):1136-1142.
84. Menon B., Singh M., Ross R.S., Johnson J.N., Singh K. Beta-adrenergic receptor-stimulated apoptosis in adult cardiac myocytes involves MMP-2-mediated disruption of beta1 integrin signaling and mitochondrial pathway. Am J Physiol Cell Physiol Jan 2006, 290(1):C254-C261.
85. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., et al. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res Feb 7 2003, 92(2):136-138.
86. Nagasaka S., Katoh H., Niu C.F., Matsui S., Urushida T., Satoh H., et al. Protein kinase A catalytic subunit alters cardiac mitochondrial redox state and membrane potential via the formation of reactive oxygen species. Circ J Mar 2007, 71(3):429-436.
87. Rosca M., Minkler P., Hoppel C.L. Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim Biophys Acta Nov 2011, 1807(11):1373-1382.
88. Grimm D., Holmer S.R., Riegger G.A., Kromer E.P. Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat. Cardiovasc Pathol Nov-Dec 1999, 8(6):315-323.
89. Nagano M., Higaki J., Nakamura F., Higashimori K., Nagano N., Mikami H., et al. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension Jun 1992, 19(6 Pt 2):708-712.
90. D'Angelo D.D., Sakata Y., Lorenz J.N., Boivin G.P., Walsh R.A., Liggett S.B., et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A Jul 22 1997, 94(15):8121-8126.
91. Sakata Y., Hoit B.D., Liggett S.B., Walsh R.A., Dorn G.W. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation Apr 21 1998, 97(15):1488-1495.
92. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science Sep 21 1984, 225(4668):1365-1370.
93. van Biesen T., Hawes B.E., Luttrell D.K., Krueger K.M., Touhara K., Porfiri E., et al. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature Aug 31 1995, 376(6543):781-784.
94. Allo S.N., McDermott P.J., Carl L.L., Morgan H.E. Phorbol ester stimulation of protein kinase C activity and ribosomal DNA transcription. Role in hypertrophic growth of cultured cardiomyocytes. J Biol Chem Nov 15 1991, 266(32):22003-22009.
95. McDermott P.J., Carl L.L., Conner K.J., Allo S.N. Transcriptional regulation of ribosomal RNA synthesis during growth of cardiac myocytes in culture. J Biol Chem Mar 5 1991, 266(7):4409-4416.
96. Gillespie-Brown J., Fuller S.J., Bogoyevitch M.A., Cowley S., Sugden P.H. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J Biol Chem Nov 24 1995, 270(47):28092-28096.
97. Vermulst M., Wanagat J., Kujoth G.C., Bielas J.H., Rabinovitch P.S., Prolla T.A., et al. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet Apr 2008, 40(4):392-394.
98. Corral-Debrinski M., Shoffner J.M., Lott M.T., Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res Sep 1992, 275(3-6):169-180.
99. Arbustini E., Diegoli M., Fasani R., Grasso M., Morbini P., Banchieri N., et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol Nov 1998, 153(5):1501-1510.
100. Karamanlidis G., Bautista-Hernandez V., Fynn-Thompson F., Del Nido P., Tian R. Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail Nov 2011, 4(6):707-713.
101. Ide T., Tsutsui H., Hayashidani S., Kang D., Suematsu N., Nakamura K., et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res Mar 16 2001, 88(5):529-535.
102. Anan R., Nakagawa M., Miyata M., Higuchi I., Nakao S., Suehara M., et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation Feb 15 1995, 91(4):955-961.
103. Pollack Y., Kasir J., Shemer R., Metzger S., Szyf M. Methylation pattern of mouse mitochondrial DNA. Nucleic Acids Res Jun 25 1984, 12(12):4811-4824.
104. Collins L.V., Hajizadeh S., Holme E., Jonsson I.M., Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol Jun 2004, 75(6):995-1000.
105. Raoof M., Zhang Q., Itagaki K., Hauser C.J. Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J Trauma Jun 2010, 68(6):1328-1332. [discussion 32-4].
106. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature Mar 4 2010, 464(7285):104-107.
107. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med May 2007, 13(5):619-624.
108. Oka T., Hikoso S., Yamaguchi O., Taneike M., Takeda T., Tamai T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature May 10 2012, 485(7397):251-255.
109. Lai L., Leone T.C., Zechner C., Schaeffer P.J., Kelly S.M., Flanagan D.P., et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev Jul 15 2008, 22(14):1948-1961.
110. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest Oct 2000, 106(7):847-856.
111. Garnier A., Fortin D., Zoll J., N'Guessan B., Mettauer B., Lampert E., et al. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J Jan 2005, 19(1):43-52.
112. Wang J., Wilhelmsson H., Graff C., Li H., Oldfors A., Rustin P., et al. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet Jan 1999, 21(1):133-137.
113. Larsson N.G., Wang J., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet Mar 1998, 18(3):231-236.
114. Ikeuchi M., Matsusaka H., Kang D., Matsushima S., Ide T., Kubota T., et al. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation Aug 2 2005, 112(5):683-690.
115. Jamshidi Y., Montgomery H.E., Hense H.W., Myerson S.G., Torra I.P., Staels B., et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation Feb 26 2002, 105(8):950-955.
116. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell Oct 1999, 4(4):585-595.
117. Asakawa M., Takano H., Nagai T., Uozumi H., Hasegawa H., Kubota N., et al. Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation Mar 12 2002, 105(10):1240-1246.
118. Barger P.M., Brandt J.M., Leone T.C., Weinheimer C.J., Kelly D.P. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest Jun 2000, 105(12):1723-1730.
119. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest Jan 2002, 109(1):121-130.
120. Wang S., Fu C., Wang H., Shi Y., Xu X., Chen J., et al. Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. Clin Chem Lab Med 2007, 45(8):962-967.
121. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell Mar 20 1998, 92(6):829-839.
122. Meirhaeghe A., Crowley V., Lenaghan C., Lelliott C., Green K., Stewart A., et al. Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J Jul 1 2003, 373(Pt 1):155-165.
123. Vega R.B., Huss J.M., Kelly D.P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol Mar 2000, 20(5):1868-1876.
124. Wu Z., Puigserver P., Andersson U., Zhang C., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell Jul 9 1999, 98(1):115-124.
125. Riehle C., Wende A.R., Zaha V.G., Pires K.M., Wayment B., Olsen C., et al. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res Sep 16 2011, 109(7):783-793.
126. Arany Z., Novikov M., Chin S., Ma Y., Rosenzweig A., Spiegelman B.M. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc Natl Acad Sci U S A Jun 27 2006, 103(26):10086-10091.
127. Lehman J.J., Boudina S., Banke N.H., Sambandam N., Han X., Young D.M., et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Jul 2008, 295(1):H185-H196.
128. Gundewar S., Calvert J.W., Jha S., Toedt-Pingel I., Ji S.Y., Nunez D., et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res Feb 13 2009, 104(3):403-411.
129. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation Oct 2 2001, 104(14):1664-1669.
130. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell Oct 20 2006, 127(2):397-408.
131. Rohas L.M., St-Pierre J., Uldry M., Jager S., Handschin C., Spiegelman B.M. A fundamental system of cellular energy homeostasis regulated by PGC-1alpha. Proc Natl Acad Sci U S A May 8 2007, 104(19):7933-7938.
132. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab Jan 2005, 1(1):15-25.
133. Dorner A., Pauschinger M., Schwimmbeck P.L., Kuhl U., Schultheiss H.P. The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. J Am Coll Cardiol Jun 2000, 35(7):1778-1784.
134. Schultheiss H.P., Bolte H.D. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol Jun 1985, 17(6):603-617.
135. Shinde S.B., Save V.C., Patil N.D., Mishra K.P., Tendolkar A.G. Impairment of mitochondrial respiratory chain enzyme activities in tetralogy of Fallot. Clin Chim Acta Feb 2007, 377(1-2):138-143.